May 2019

May 17th, 2019

NIH administers first clinical trial treatment for GM1 created by Auburn, UMass

Milestone marks the first patient with GM1 gangliosidosis treated with gene therapy The first clinical trial of a gene therapy treatment created through a research alliance between Auburn University and the University of Massachusetts has been administered in a child at the National Institutes of Health, or NIH, in Bethesda, Maryland. The NIH clinical trial […]

February 2019

Feb 22nd, 2019

Auburn University senior is on a mission for a cure for GM1

When Auburn University senior Cassie Bebout was 6 years old, her 9-year-old brother Jake died from GM1, a rare genetic disease with no cure. Cassie’s life was changed forever. The senior molecular biology major, who will earn her bachelor’s degree in May, has devoted her college career to helping find a possible cure for the […]

October 2018

Oct 11th, 2018

Auburn Veterinary Medicine, UAB part of joint NIH study of glioma brain cancer

People and animals suffering from the deadliest form of brain cancer are undergoing similar treatment in an NIH-funded clinical trial through the University of Alabama at Birmingham, Auburn University’s College of Veterinary Medicine and two other currently enrolled Southeastern veterinary programs. Veterinarians and human medical doctors are collaborating on an NIH-funded clinical trial in which […]